You have free access to this content

Patterns of tobacco exposure before and during pregnancy

  1. MARLENE ANDERKA1,*,
  2. PAUL A. ROMITTI2,
  3. LIXIAN SUN2,
  4. CHARLOTTE DRUSCHEL3,
  5. SUZAN CARMICHAEL4,
  6. GARY SHAW5,
  7. the National Birth Defects Prevention Study

Article first published online: 31 DEC 2010

DOI: 10.3109/00016341003692261

Issue

Acta Obstetricia et Gynecologica Scandinavica

Acta Obstetricia et Gynecologica Scandinavica

Volume 89, Issue 4, pages 505–514, April 2010

Additional Information

How to Cite

ANDERKA, M., ROMITTI, P. A., SUN, L., DRUSCHEL, C., CARMICHAEL, S., SHAW, G. and the National Birth Defects Prevention Study (2010), Patterns of tobacco exposure before and during pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 89: 505–514. doi: 10.3109/00016341003692261

Author Information

  1. 1

    Massachusetts Department of Public Health, Massachusetts Center for Birth Defects Research and Prevention, Boston, MA, USA

  2. 2

    Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA, USA

  3. 3

    New York State Department of Health, Congenital Malformations Registry, Albany, NY, USA

  4. 4

    March of Dimes Foundation, California Research Division, Oakland, California, USA

  5. 5

    Department of Pediatrics, Stanford University, Stanford, California, USA

* Marlene Anderka, Massachusetts Department of Public Health, Massachusetts Center for Birth Defects Research and Prevention, 250 Washington Street, 5th floor, Boston, MA, 02108, USA. E-mail: marlene.anderka@state.ma.us

Publication History

  1. Issue published online: 31 DEC 2010
  2. Article first published online: 31 DEC 2010
  3. (Received 29 October 2009; accepted 10 February 2010)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (181K)

Keywords:

  • Maternal smoking;
  • environmental tobacco smoke;
  • nicotine replacement therapy

Abstract

Objectives. To describe maternal exposure to tobacco in the three months before conception and throughout pregnancy, examine risk factors associated with tobacco exposure in pregnancy and smoking cessation, assess use of pharmacotherapy for smoking cessation and evaluate birth outcomes by smoking status. Design. A cohort of women from a multi-site United States study were asked retrospectively about their exposure to tobacco. Population. The study population was comprised of 4,667 mothers of non-malformed control infants who participated in the National Birth Defects Prevention Study from 1997 to 2003. Methods. Using computer-assisted telephone interview responses from this population-based sample, we assessed patterns of maternal smoking and exposure to environmental tobacco smoke (ETS) as well as use of pharmacotherapy for quitting smoking during pregnancy. Results. Overall, 961 (20.6%) mothers reported any smoking and 1,401 (30.0%) reported any exposure to ETS at home or work during the three months before conception through pregnancy. Of the 961 smokers, 512 (53.3%) reportedly quit smoking before or during pregnancy, including 379 (74% of quitters) in the first trimester, and 420 (43.7%) continued to smoke throughout the pregnancy. Only 2.1% of smokers reportedly used pharmacotherapy to quit smoking anytime from three months before conception through pregnancy. Low birthweight and preterm delivery rates were lowest among offspring of non-smokers and highest in offspring of those who continued to smoke throughout pregnancy. Conclusions. About one-half of mothers who reported preconceptional smoking quit before or during pregnancy. Use of pharmacotherapy to quit smoking during pregnancy was not common.

View Full Article (HTML) Get PDF (181K)